Perception of availability and ease of access to COVID-19 vaccination in Nigeria: a cross-sectional study
Sidney Sampson, Sunday Atobatele, Oluwafisayo Ayodeji, Adebisi Adenipekun, Saheed Dipo Isiaka, Stephen Olabode Asaolu, Gab-Deedam Shiva, Emmanuella Nzeribe, Olugbemisola Samuel

TL;DR
This study explores how people in Nigeria perceive the availability and ease of access to COVID-19 vaccines, finding that non-healthcare workers and rural residents face more challenges.
Contribution
The study provides new insights into vaccine accessibility perceptions among different groups in Nigeria, highlighting the influence of occupation and location.
Findings
Non-healthcare workers were significantly more likely to perceive difficulties in accessing vaccines compared to healthcare workers.
Rural residents reported more challenges in vaccine access than urban residents.
Perceptions of vaccine availability and accessibility were influenced by location, suggesting a need for more vaccination points in rural areas.
Abstract
the government of Nigeria, through concerned agencies/authorities, is ensuring a large-scale and equitable distribution of COVID-19 vaccination across the country. To understand how the eligible population accesses these vaccines, we assessed the perception of availability and accessibility of the COVID-19 vaccines in Nigeria. the study was part of a larger cross-sectional survey conducted in Nigeria between July and August 2021 to understand broader behavioral, social, and access-related drivers of COVID-19 vaccines among healthcare workers (HCW) and non-healthcare workers (NHCWs) using a data tool adapted from the World Health Organization (WHO) guidance on behavioral and social drivers of vaccination. Data was collected from 1548 respondents across 8 Nigerian states using a multistage sampling approach and analyzed descriptively and inferentially, using SPSS Version 20 to understand…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVaccine Coverage and Hesitancy · COVID-19 epidemiological studies · COVID-19 Pandemic Impacts
